Results 201 to 210 of about 56,684 (297)

Sensitizer-Induced Basophils Accelerate Skin Re-Epithelialization via IL-4/IL-13-Mediated Macrophage Polarization. [PDF]

open access: yesAllergy
Zhang Y   +14 more
europepmc   +1 more source

The Basophil Activation Test in Allergy Diagnostics: Clinical Applications, Methodological Challenges, and Proposed Clinical Frameworks. [PDF]

open access: yesCells
Izmailovich M   +11 more
europepmc   +1 more source

Codocytosis in the Dog: 345 Cases (2020–2022)

open access: yesVeterinary Clinical Pathology, EarlyView.
ABSTRACT Introduction Codocytes, or target cells, are a morphologic variation of erythrocytes characterized by increased membrane surface area relative to volume. In dogs, codocytosis is frequently noted on blood smear evaluation, but its clinical significance remains poorly understood. Objectives To characterize the clinical conditions associated with
Sarena M. Krojanker   +5 more
wiley   +1 more source

A functional cell model using basophil activation test to study molecular mechanisms and biomarkers of response to omalizumab treatment in patients with asthma. [PDF]

open access: yesFront Immunol
Gole B   +14 more
europepmc   +1 more source

Evaluation of the IDEXX Procyte Dx Analyzer for the Measurement of Total and Differential Cellular Counts of Bronchoalveolar Lavage Fluid in Healthy Beagles and Dogs with Lower Respiratory Tract Diseases

open access: yesVeterinary Clinical Pathology, EarlyView.
ABSTRACT Background Bronchoalveolar lavage fluid (BALF) analysis is a key diagnostic tool in veterinary respiratory medicine. The IDEXX ProCyte Dx analyzer was developed for blood formulation and cellular counting in various fluids, but its applicability for BALF analysis remains unexplored.
Hélène Machiels   +9 more
wiley   +1 more source

Analysis of ADVIA Myeloperoxidase Cytogram LUC Angle Does Not Distinguish Acute Myeloid Leukemia From Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma in Dogs

open access: yesVeterinary Clinical Pathology, EarlyView.
ABSTRACT Background Acute myeloid leukemia (AML) is difficult to distinguish from lymphoblastic leukemia or lymphoma (LL) on morphologic features alone. Therapeutic approaches for AML versus LL differ, and immediate therapy is often needed due to patient illness and rapid disease progression.
Mayzie Miller   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy